For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
FDA’s Juul Ban Part of Deadly War on Nicotine
The U.S. Food and Drug Administration (FDA) today announced that it denied the application of Juul Labs, maker of the Juul e-cigarette, to market its…
The City Journal
Better Late Than Never?
The federal requirement for a negative Covid-19 test prior to flying into the U.S. and the New York City toddler-mask mandate have both just ended.
Wall Street Journal
A Permanent Pandemic Means a Huge Medicaid Expansion
Covid is now endemic, yet the Biden administration keeps extending the public-health emergency. Its goal is to preserve the expansion of the welfare state through…
Search Posts
National Review
Now, Voyager: Ending the Covid Travel-Testing Charade
As Covid-19 cases, hospitalizations, and deaths continue to plummet, lawmakers around the country are beginning to lift restrictions. The Biden administration, however, is clinging to…
Forbes
Yes, Cannabis Banking Liberalization — SAFE Banking Act — Would Indeed Make U.S. More Competitive
As war continues in the aftermath of Russia’s invasion of Ukraine, interest by policymakers and the media has spiked in the America COMPETES Act, legislation…
New York Post
CDC’s Silly Stalling on Flight Masks
The Transportation Security Administration, following the recommendation of the Centers for Disease Control and Prevention, will extend its mask mandate for airplanes through mid-April. Once again,…
Op-Eds
Watch Us Fight Covid
The Biden administration’s 97-page National Covid-19 Preparedness Plan, released this month, features a “Test to Treat” initiative that would set up “one-stop”…
Reason
Can the FDA’s New Commissioner Save the Agency from Itself?
Public trust in the U.S Food and Drug Administration (FDA) is at an all-time low, largely due to its bumbled handling of the pandemic. But…
Letters
CEI Joins Coalition Opposing March-In over Drug Prices
Dear Secretary Becerra, On behalf of millions of Americans across the country, we urge you to ignore calls and petitions asking you to deliberately twist…
